The US Food and Drug Administration (FDA) has accepted priority review of the new drug application (NDA) for Roche’s investigational…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
Immunotherapy has fundamentally reshaped the landscape of lung cancer treatment, offering a beacon of hope and significantly improving patient prognoses.…
Read More
ASCO 2026 Delivers Promising Advances and Crucial Data in Blood Cancer Treatment
The 2026 American Society of Clinical Oncology (ASCO) conference, a cornerstone event for oncological advancements, has concluded, leaving a significant…
Read More
Revolution Medicines’ Daraxonrasib Achieves Landmark Survival Extension in Pancreatic Cancer, Heralding New Era of Targeted Therapy
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer. The 2026…
Read More
ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
Breakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Offers New Therapeutic Pathways
In a significant advancement for the field of oncology, a collaborative study led by investigators at the Johns Hopkins Kimmel…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Researchers Recreate Human Bone Marrow Niche Using Pluripotent Stem Cells to Advance Cancer Research and Reduce Animal Testing
In a significant advancement for regenerative medicine and oncology, a multidisciplinary team of scientists from the University of Basel and…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
How breast cancer cells survive in bone marrow after remission
The Challenge of Estrogen Receptor-Positive Breast Cancer Estrogen receptor-positive (ER+) breast cancer represents approximately 70% to 80% of all breast…
Read MoreYOU MAY HAVE MISSED
